themarben.com
Antitrust: Commission sends Statement of Objections to Teva on ‘pay for delay’ pharma agreement
The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust rules. Under the agreement, Teva com…